<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04774666</url>
  </required_header>
  <id_info>
    <org_study_id>CDC IRB 7292</org_study_id>
    <nct_id>NCT04774666</nct_id>
  </id_info>
  <brief_title>Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Uganda</brief_title>
  <official_title>Caregiver-Assisted Oral Fluid-based HIV Screening in Children: Estimation of Acceptability, Feasibility and Effectiveness Linked to Index Testing Services in Uganda</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic Relief Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centers for Disease Control and Prevention</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic Relief Services</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the acceptability, feasibility and effectiveness of&#xD;
      a caregiver-assisted oral fluid-based HIV test to screen children for HIV. The results of&#xD;
      this study are intended to support expanded access to HIV testing and treatment services for&#xD;
      children, and to ensure that all newly diagnosed children are linked to clinical care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: Globally, there are 1.8 million children living with HIV (CLHIV), however, despite&#xD;
      great progress over the past 15 years, only 52% are receiving antiretroviral therapy (ART),&#xD;
      leaving approximately 864,000 children in need of treatment.1 Pediatric case finding is the&#xD;
      first, critical step to close the pediatric ART gap. In Uganda, there are an estimated 36,873&#xD;
      CLHIV in need of HIV treatment.2 Reaching this population is challenging, because children&#xD;
      are dependent on parents and caregivers to access HIV testing services. Parents and&#xD;
      caregivers often face logistical, societal and other barriers that limit the uptake of&#xD;
      testing services for children. In order to achieve the second and third UNAIDS 95 targets for&#xD;
      pediatric HIV treatment coverage and viral load suppression to reach epidemic control,&#xD;
      country programs need to utilize increasingly targeted and innovative testing modalities to&#xD;
      optimize the identification CLHIV. Oral fluid-based screening may present a safe, convenient&#xD;
      and reliable way to identify CLHIV that can expand access to essential testing services in&#xD;
      resource-limited settings where most CLHIV reside.&#xD;
&#xD;
      Methods: The study will use a cross-sectional cluster sampling design, in which 32 facilities&#xD;
      in 16 districts will be selected using probability-proportional-to-size (PPS) sampling. In&#xD;
      the 32 selected facilities, index parent/caregivers of approximately 4,687 children will be&#xD;
      recruited to accept test kits for their children. Adult index parent/caregivers will be&#xD;
      consented to participate in the study and asked for parental permission for their child(ren)&#xD;
      to participate, given a number of oral screening kits corresponding to the number of children&#xD;
      eligible for screening, and followed-up to confirm the oral fluid-based screening results and&#xD;
      participate in a testing experience survey. Any children who screen HIV reactive will receive&#xD;
      confirmatory testing and active linkage to care and treatment services. A cost analysis which&#xD;
      includes savings associated with facility or home-based costs averted, using existing sources&#xD;
      to estimate the costs of facility-based testing and home-based by a community health worker&#xD;
      (CHW), preferably from antenatal settings will be undertaken.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Estimate the acceptability of implementing caregiver-assisted oral fluid-based HIV screening of children as part of index testing services for HIV-positive adults.</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of eligible index parent/caregivers (disaggregated by sex) that accepted an oral fluid-based HIV screening kit as part of innovative index testing services for their eligible children when first offered.&#xD;
Proportion of eligible index parent/caregivers (disaggregated by sex) that accepted an oral fluid-based HIV screening kit as part of innovative index testing services for their eligible children when they returned for a subsequent visit.&#xD;
Proportion of eligible children (i.e. unknown HIV status) screened with an oral fluid-based HIV screening kit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate the feasibility of implementing caregiver-assisted oral fluid-based HIV screening for children as part of index testing services for HIV-positive adults.</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of index parent/caregivers who reported that the caregiver-assisted oral fluid-based HIV screening kit to screen children for HIV was easy to use.&#xD;
Proportion of index parent/caregivers who reported needing additional assistance with administering the oral fluid-based HIV screening kit.&#xD;
Proportion of index parent/caregivers who reported adverse events related to the use of caregiver-assisted oral fluid-based HIV screening kits to screen their children for HIV.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimate the effectiveness of caregiver-assisted oral fluid-based HIV screening on testing yield, return to clinic, and linkage to ART for newly identified CLHIV.</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of eligible children screened reactive through a caregiver-assisted oral fluid-based HIV screening kit (i.e., yield).&#xD;
Proportion of eligible children who screened reactive through a caregiver-assisted oral fluid-based HIV screening kit who received confirmatory testing, within 1 day, 1 week, 1 month of their reactive screen.&#xD;
Proportion of eligible children who screened reactive through a caregiver-assisted oral fluid-based HIV screening kit who were started on ART within 1 day, 1 week, 1 month of their confirmatory test.&#xD;
Proportion of index parent/caregivers who were offered an oral fluid-based test kit to screen their eligible children for HIV used it.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estimate the cost of caregiver-assisted oral fluid-based HIV screening compared to the standard cost of the existing referral to testing program, from the perspective of the health care provider.</measure>
    <time_frame>6 months</time_frame>
    <description>Comparative costs between oral fluid-based screening and the costs of the existing referral to testing program, from the perspective of the health care provider.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2997</enrollment>
  <condition>HIV Testing</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Acceptability of OraQuick AdvanceÂ© Rapid HIV-1/2 Antibody screening</intervention_name>
    <description>Oral fluid-based HIV test</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        At the 32 PEPFAR-supported government health facilities, eligible adult index parents and&#xD;
        their eligible children will be recruited during post-test counseling sessions when they&#xD;
        are newly-diagnosed as HIV-positive, and/or at the ART clinic and/or mother-baby care point&#xD;
        (MBCP).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Index parent/caregivers:&#xD;
&#xD;
          -  HIV-positive diagnosis&#xD;
&#xD;
          -  18 years old or older&#xD;
&#xD;
          -  Emancipated minors (15-17 years of age) with eligible children&#xD;
&#xD;
        Inclusion Criteria for eligible children:&#xD;
&#xD;
          -  Biological children (of an index parent/caregiver) 18 months - 14 years of age with an&#xD;
             unknown HIV status&#xD;
&#xD;
          -  Non-biological children living in the same household as the index parent/caregivers&#xD;
             where the child has a history of HIV exposure (where the mother is HIV-positive, of&#xD;
             unknown status, unavailable for testing, or who is deceased)&#xD;
&#xD;
          -  Biological children (of an index parent/caregiver) 18 months - 14 years of age, as&#xD;
             well as non-biological children living in the same household as the index&#xD;
             parent/caregiver where the child has a history of HIV exposure (where the mother is&#xD;
             HIV-positive, of unknown status, unavailable for testing, or who is deceased), with a&#xD;
             known previous HIV-negative status completed less than three months following the&#xD;
             cessation of breastfeeding and whose parent/caregiver states that there is reason to&#xD;
             suspect a new exposure&#xD;
&#xD;
        Inclusion criteria for participation in survey after completion of care giver-assisted oral&#xD;
        fluid-based HIV screening:&#xD;
&#xD;
        â¢ Adult index parents who complete the oral-based HIV screening with at least one eligible&#xD;
        child, regardless of screening result.&#xD;
&#xD;
        Exclusion Criteria for Index parent/caregivers:&#xD;
&#xD;
          -  Adults answering &quot;yes&quot; to any of the first three intimate partner violence (IPV) risk&#xD;
             assessment questions&#xD;
&#xD;
          -  Adults answering &quot;yes&quot;, &quot;maybe&quot; or I don't know&quot; to the fourth IPV question&#xD;
&#xD;
          -  Those unable to provide independent informed consent due to mental disability or other&#xD;
             limitations (as deemed by study staff)&#xD;
&#xD;
        Exclusion Criteria for eligible children:&#xD;
&#xD;
          -  Children &lt;18 months of age&#xD;
&#xD;
          -  Children 18 months - 14 years of age with a known HIV-positive status&#xD;
&#xD;
          -  Biological children (of an index parent/caregiver) 18 months - 14 years of age where&#xD;
             the child has a history of HIV exposure (where the mother is HIV-positive, of unknown&#xD;
             status, unavailable for testing, or who is deceased), with previous known HIV-negative&#xD;
             status completed less than three months following the cessation of breastfeeding and&#xD;
             whose parent/caregiver states that they have no reason to suspect a new exposure&#xD;
&#xD;
          -  Non-biological children living in the same household as the index parent/caregiver age&#xD;
             where the child has a history of HIV exposure (where the mother is HIV-positive, of&#xD;
             unknown status, unavailable for testing, or who is deceased), with previous known&#xD;
             HIV-negative status completed less than three months following the cessation of&#xD;
             breastfeeding and whose parent/caregiver states that they have no reason to suspect a&#xD;
             new exposure&#xD;
&#xD;
          -  Children still breastfeeding&#xD;
&#xD;
          -  Children with cessation of breastfeeding &lt; 3 months&#xD;
&#xD;
        Exclusion criteria for participation in survey after completion of oral-based HIV&#xD;
        screening:&#xD;
&#xD;
        â¢ Adult index parent/caregivers who do not complete the oral-based HIV screening with at&#xD;
        least one eligible child&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl C Stecker, EdD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catholic Relief Services - USCCB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carl C Stecker, EdD</last_name>
    <phone>719-985-5051</phone>
    <email>carl.stecker@crs.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francis Okello, MPH</last_name>
    <phone>+256-771-401-619</phone>
    <email>Francis.Okello@crs.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bugiri Hospital</name>
      <address>
        <city>Bugiri</city>
        <state>Bugiri District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc. QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nankoma HC IV</name>
      <address>
        <city>Bugiri</city>
        <state>Bugiri District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kabuyanda HC IV</name>
      <address>
        <city>Kabuyanda</city>
        <state>Isingiro District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.orkell@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rwekubo HC IV</name>
      <address>
        <city>Kahirimbi</city>
        <state>Isingiro District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Buremba HC III</name>
      <address>
        <city>Kazo</city>
        <state>Kazo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kazo HC IV</name>
      <address>
        <city>Kazo</city>
        <state>Kazo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Butunduzi HC III</name>
      <address>
        <city>Kyenjojo</city>
        <state>Kyenjojo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kigarale HC III</name>
      <address>
        <city>Kyenjojo</city>
        <state>Kyenjojo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kasaali HC III</name>
      <address>
        <city>Kyotera</city>
        <state>Kyotera District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barr HC III</name>
      <address>
        <city>Lira</city>
        <state>Lira District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lira Regional Ref Hospital</name>
      <address>
        <city>Lira</city>
        <state>Lira District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Luwero HC IV</name>
      <address>
        <city>Kampala</city>
        <state>Luwero District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Luke Namaliga HC III</name>
      <address>
        <city>Kampala</city>
        <state>Luwero District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinoni HC III</name>
      <address>
        <city>Bukoto</city>
        <state>Lwengo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kiwangala HC III</name>
      <address>
        <city>Mbirizi</city>
        <state>Lwengo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kiyumba HC IV</name>
      <address>
        <city>Bukoto</city>
        <state>Masaka District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Buwunga HC III</name>
      <address>
        <city>Masaka</city>
        <state>Masaka District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mbarara Regional Ref Hospital</name>
      <address>
        <city>Mbarara</city>
        <state>Mbarara District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nyamityobora HC II</name>
      <address>
        <city>Mbarara</city>
        <state>Mbarara District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kyantungo HC IV</name>
      <address>
        <city>Mityana</city>
        <state>Mityana District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mityana Hospital</name>
      <address>
        <city>Mityana</city>
        <state>Mityana District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mubende Kasambya HC III</name>
      <address>
        <city>Mubende</city>
        <state>Mubende District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nabingoola HC III</name>
      <address>
        <city>Nabingora</city>
        <state>Mubende District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mukono Cou HC IV</name>
      <address>
        <city>Mukono</city>
        <state>Mukono District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seeta-Nazigo HC III</name>
      <address>
        <city>Nakisunga</city>
        <state>Mukono District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kitwe HC IV</name>
      <address>
        <city>Kitwe</city>
        <state>Ntungamo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ntungamo HC IV</name>
      <address>
        <city>Ntungamo</city>
        <state>Ntungamo District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lwamaggwa HC III</name>
      <address>
        <city>Rakai</city>
        <state>Rakai District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rakai Hospital</name>
      <address>
        <city>Rakai</city>
        <state>Rakai Distsrict</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kajjansi HC III</name>
      <address>
        <city>Busiro</city>
        <state>Wakiso District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kasangati HC IV</name>
      <address>
        <city>Kasangati</city>
        <state>Wakiso District</state>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mitukula HC III</name>
      <address>
        <city>Kyotera</city>
        <country>Uganda</country>
      </address>
    </facility>
    <contact>
      <last_name>Francis Okello, BSc, MSc QE</last_name>
      <phone>+256 782 733 475</phone>
      <email>francis.okello@crs.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 9, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>February 24, 2021</last_update_submitted>
  <last_update_submitted_qc>February 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

